The antibiotics erythromycin and kanamycin, members of the macrolide and aminoglycoside classes respectively, have their importance as preservative agents for the preparation process and during the using of the yellow fever vaccine, five doses presentation, produced in Technology on Immunobiologicals Institute, Bio- Manguinhos, FIOCRUZ, RJ. In this work two new approaches for the spectrofluorimetric determination of these antibiotics are presented, taking into consideration their selectivity performance for this specific matrix (vaccine). A preliminary study was performed to evaluate the luminescent behavior (phosphorescence and fluorescence) of these substances in different experimental conditions aiming to find the best ones that would lead to the development of the analytical methods. For erythromycin, which does not present native luminescence, a photochemical derivatization was employed using analite solutions prepared in sulfuric acid. As a result, a photo- product was obtained, which presented fluorescence at 412/465 nm. The experimental conditions were optimized aiming the maximization of the fluorescent signal. In this case, the studied parameters were the UV irradiation time, the type and concentration of the acid utilized, and the time and temperature used for the heating step. The method was partially validated, indicating limits of detection and quantification of 0.25 ug mL-1 and 0.85 ug mL-1, respectively. The linear dynamic range of the method extended up to 200 ug mL-1 and the parameters related to precision and robustness were very satisfactory. The method was applied in the analysis of a simulated yellow fever vaccine and in commercial pharmaceutical formulations. Recovery percent between 98.2 and 105.2 % were achieved. The methodology developed for kanamycin, which also do not presented natural fluorescence, was based on the oxirreduction reaction of this compound with Ce (IV), producing Ce (III), a strongly fluorescent species (255/360 nm). The fluorescence intensities, measured in the excitation/emission pair of Ce (III), was directly proportional to the kanamycin concentration. The reaction conditions were studied by the evaluation of the amount of Ce (IV), the type and concentration of the acid utilized in reactional medium and heating time and temperature. Large linear range (up to 1000 ug mL-1) was obtained, with detection and quantification limits of 1.22 ug mL-1 and 4.08 ug mL-1, respectively. The recovery percent obtained in the analysis of a diluted vaccine was 109.8 % while the recovery achieved for diluted spiked urine was 103.4 %.